Clinical Trials Logo

Filter by:
NCT ID: NCT00653887 Terminated - Constipation Clinical Trials

Biofeedback and Cortical Excitability

Biofeedback
Start date: January 2008
Phase: N/A
Study type: Interventional

Looking for a modification of the cortical excitability of the motor area corresponding to the external anal sphincter after biofeedback sessions.

NCT ID: NCT00647465 Terminated - Influenza Infection Clinical Trials

Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer

GP-INFA
Start date: October 2005
Phase: Phase 3
Study type: Interventional

Influenza vaccination reduces the morbidity and mortality associated with influenza infection in at risk groups including the elderly and individuals with an impaired immune response, but is not totally protective in all recipient. Cytokines including type I interferons are known to play a key role in the innate immune response to virus infection and in the induction of the primary adaptive-immune response. Thus, we evaluated the safety of sublingual administration of IFNa and its effect on immune response to influenza vaccination in a randomized double-blind placebo controlled study in elderly institutionalized individuals.

NCT ID: NCT00647140 Terminated - Thyroid Carcinoma Clinical Trials

Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer

DOPMET
Start date: August 2007
Phase: Phase 2
Study type: Interventional

Medullary thyroid carcinoma (MTC) is a rare tumor arising from C cells of the thyroid gland and belonging to the endocrine tumors. 18F-DOPA PET, based on tha capacity of endocrine tumor cells to take-up, decarboxylate and store amino-acids, such 3-4-dihydroxyphenylalanine(DOPA), is used for imaging endocrine tumors. The aim of the study was to evaluate the contribution of 18F-DOPA whole-body PET for the detection of recurrences in patients with proven recurrent MTC without evidence of recurrence or metastases on several imaging modalities.

NCT ID: NCT00646971 Terminated - Oxidative Stress Clinical Trials

Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea

SOREVAS
Start date: January 2008
Phase: N/A
Study type: Interventional

Patients with sleep apnea syndrome have repeated apneic events that induce periodic hypoxia-reoxygenation, drawing away an overproduction of oxidants. This exaggerated generation of oxidants is associated with a dysfunction of the vascular endothelium that evolves, in its turn, towards cardiovascular diseases such as systemic hypertension, stroke, and myocardial infarction. The major aim of our study is to examine the effect of CPAP treatment on biochemical (markers of oxidative stress) and functional (endothelium-dependent vascular relaxation reactivity) abnormalities at 1 and 4 weeks of treatment.

NCT ID: NCT00644306 Terminated - Clinical trials for Newly Diagnosed, Multiple Myeloma

Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma

IFM 01/01
Start date: April 2002
Phase: Phase 3
Study type: Interventional

In multiple myeloma, combination chemotherapy with melphalan plus prednisone has been usedsince the 1960s and is regarded as the standard of care in very elderly patients. We assess whether the addition of thalidomide at 100 mg/day to this combination would improve survival.

NCT ID: NCT00643786 Terminated - Clinical trials for Dental Cares Under Kalinox's Inhalation

Interest of Re-oxygenation After Inhalation of 50% Nitrous Oxide / 50% Oxygen Premix in Dental Cares

Start date: February 2004
Phase: Phase 3
Study type: Interventional

The usefulness of re-oxygenation after inhalation of 50% nitrous oxide and 50% oxygen premix (Kalinox 170 bar) during dental care is studied and the pollution resulting from administration of Kalinox is also investigated.

NCT ID: NCT00642941 Terminated - Sarcoma Clinical Trials

A Study of R1507 in Participants With Recurrent or Refractory Sarcoma

Start date: December 18, 2007
Phase: Phase 2
Study type: Interventional

The study was primarily designed to determine objective response, progression-free survival (PFS), and the safety and tolerability of R1507 in participants with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas including alveolar soft part sarcoma, desmoplastic small round cell tumor, extraskeletal myxoid chondrosarcoma, clear cell sarcoma, and myxoid liposarcoma.

NCT ID: NCT00642902 Terminated - Clinical trials for Relapsing Multiple Sclerosis

Atacicept in Multiple Sclerosis, Phase II

Start date: March 2008
Phase: Phase 2
Study type: Interventional

To evaluate the safety and tolerability of atacicept and to explore if atacicept reduces Central Nervous System inflammation in subjects with RMS as assessed by frequent MRI. This study is randomised. Study medication is administered via subcutaneous (under the skin) injections.

NCT ID: NCT00642135 Terminated - Premature Birth Clinical Trials

CLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference Treatment

Start date: January 2006
Phase: Phase 3
Study type: Interventional

Pupillary dilation to perform a fundus in premature newborns and neonates is often difficult to obtain, because of the non mature iris sphincter. The fundus is essential to detect retinal anomalies (as retinopathy of prematurity or chorioretinal or disk anomalies). The aim of the study is to obtain a satisfactory degree of mydriasis with a minimal dose of two mydriatic treatments, with an optimal duration and a good tolerance of the drugs. The study will evaluate the mydriasis in premature newborns, neonates and infants justifying a mydriasis for a bilateral diagnosis fundus, using ophthalmic insert Mydriasert® versus reference treatment (association of phenylephrine and tropicamide eyedrops). Ophthalmic insert Mydriasert® can control drug dispensation and decrease the number of nurse interventions to obtain mydriasis in patients.

NCT ID: NCT00640029 Terminated - Kyphosis Clinical Trials

Evaluation of the Prosthetic Disc Replacement

EVA
Start date: February 2008
Phase: N/A
Study type: Interventional

Until now, arthrodesis (intervertebral fusion) is the formal treatment for the lumbar and cervical degenerative disc disease : arthrodesis has been the standard surgical treatment for the patients when nonsurgical management has failed. However , it has shown out some drawbacks : pseudoarthrosis may appear in the short term, and junctional degeneration in the long term. The replacement of the intervertebral disc by a prosthesis (arthroplasty) has been since a few years a major alternative therapeutic to the arthrodesis.: it demonstrates great functional results and less post-interventional complications. It is indicated to restore a normal function of the spine (motion is kept)and to avoid deterioration of the adjacent spinal segments over the long time. In this clinical study, we will distinguish the cervical discal pathology and the lumbar discal pathology. The purpose of this study is to analyze the results of the arthroplasty in terms of functional effects, quality of life, anatomical results and economical results.